Your access to charitable activities
We create the best possible conditions for working for the common good.
For effective charitable activities
Financial commitment provides the underpinnings of a strong and dynamic society. Established by Reichmuth & Co more than 20 years ago, the Rütli-Foundation is an independent umbrella foundation for people who want to do charitable work.
Setting up your own foundation is often a very costly process and takes up a great deal of time and effort. You also face start-up fees and running costs which are charged to the foundation’s capital and eat into the donations. The Rütli-Foundation offers legal, management and tax services and supports you in achieving your goals for the common good efficiently and cost-effectively.
ACCORDING TO YOUR NEEDS
«Your generosity can do a lot of good. The Rütli-Foundation can help you turn your plans into reality: uniquely, simply and effectively.»
Chairman of the Rütli-Foundation
Find out more in a personal conversation about what options are available to you if you want to get involved in charitable activities.
Aktuelles
Liability instead of rescue – an appeal from private bankers to politicians
As part of a broad-based initiative to strengthen personal responsibility in the banking sector, a guest article entitled “Haften statt retten” (Liability instead of rescue) was published in the Neue Zürcher Zeitung (NZZ) on September 1, 2025. The article was written by Christian Bidermann, partner at Rahn & Bodmer and Jürg Staub, general partner at Reichmuth & Co.
Is the Swiss currency rocket taking off?
Switzerland is sitting on a ticking currency time bomb: the Swiss franc. What has been regarded as a sign of stability and solidity for years could prove highly explosive in the event of a new global economic shock. While the Swiss Confederation shines as a safe haven with one of the lowest debt ratios in the world and a credible monetary stability policy pursued by the SNB, it is precisely this status that threatens to become a challenge.
Swiss pharmaceutical industry facing political headwinds
The pharmaceutical industry is currently high on Donald Trump’s list of priorities. He wants more production and jobs in the US, as well as lower drug prices. As a means of exerting pressure, he is threatening to impose price caps and introduce tariffs on drugs. These goals are, of course, contradictory, which is causing even more uncertainty.